The KC BioHub, is a program of BioNexus KC, uniting more than 125+ organizations based in the Kansas City (KC) region. Together, we are working collaboratively to build a globally leading innovation ecosystem that develops and produces biologic medicines that extend, save, and improve lives.
About Us
The Kansas City BioHub (KC BioHub) is a consortium-driven economic development initiative advancing the Kansas City region’s biomanufacturing cluster and biologics innovation ecosystem. Our goal is to become a global leader in the industry in the next ten years.
Our consortium includes 40+ private sector members, ranging from industry leaders to CROs and CDMOs, and innovators. The KC region also includes four R-1 research universities, government agencies representing two states, 20 economic and community development organizations, 35 workforce development entities, and more.
KC BioHub
10 Year Goals
10,000
"good jobs" created
100
new biotech firms
2
new facilities for innovators
KC BioHub: An EDA-Designated Tech Hub
In 2023, the KC BioHub was declared a Tech Hub by the Economic Development Administration (EDA). The Tech Hubs program, created by the CHIPS and Science Act, designated Kansas City as one of 31 communities across the country that have the potential to become global industry leaders in emerging technology areas within ten years.
Fueling American Innovation and Protecting Our Country
The KC BioHub works to develop and manufacture biologic medicines that protect humans, animals, and our global food supply. This requires the development of innovative technologies in cutting-edge fields like synthetic biology and rapidly scaling businesses with the potential to bring new therapies to market. It also requires continued growth, improved resilience, and onshoring in the biomanufacturing industry.
Biologics Are the Future and Save Lives Today
Biologics are medicines that are developed using living tissues and organisms. These medicines represent innovations that combat emerging infectious diseases, treat cancer, and save or improve our quality of life. Biologics are more common than you might think. You likely know and love someone who relies on a biologic, whether they use insulin to treat their diabetes, Humira to manage arthritis symptoms, or a GLP-1 medication to treat type 2 diabetes and obesity. In the future, biologics will enable the personalized medicine revolution.
”I was in Kansas City to announce that the Greater Kansas City Region has been designated as a Tech Hub by the U.S. Department of Commerce. This announcement represents official recognition of something we have known in Kansas and Missouri for a while: the Kansas City Region and the Animal Health Corridor have the concentration of expertise, research and development resources necessary to be a global bio and medical technology hub. This designation will attract public and private resources to grow this key technology area in Kansas and Missouri, further expanding the region’s capacity for innovation in the biotech sector.
Jerry MoranUS Senator, R-Kansas
”The KC BioHub's designation as a Regional Tech Hub holds immense potential for the Kansas City region and Kansas as a whole. It will help companies, organizations, and academic institutions forge better partnerships to advance cutting-edge research. Critically, this prestigious designation will also create good-paying jobs and ensure the technology of the future is developed in Kansas, not overseas. The local economic growth and new discoveries, particularly in medication development, that we'll see over the coming decade cannot be overstated, and I'm glad to have worked in a bipartisan manner to bring these investments home.
Sharice DavidsUS Representative, D-Kansas
”Kansas City has long been a national leader in healthcare innovation, biomedical research, and biomanufacturing—and today’s announcement is a recognition that the work we’re doing in the region has been noticed at the highest levels of the federal government.
Emanuel CleaverUS Representative, D-Missouri
”The wins keep coming for Kansas City. Out of 300+ applications nationwide, we were selected as one of 31 communities to be designated a Tech Hub by the EDA. This means millions in federal investment and thousands of jobs in bio manufacturing from Columbia to Manhattan.
Quinton LucasKansas City Mayor
Our Consortium
KC BioHub Partners
The KC BioHub Consortium includes 125+ businesses and organizations across Kansas and Missouri, including industry partners, entrepreneurs, small businesses, academic institutions, workforce developers, government agencies, economic development organizations, and other non-profit organizations.
